Thomas Doyle - Jan 28, 2025 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
SVP, Finance & Accounting
Signature
Teresa Bair, Attorney-in-fact for Thomas Doyle
Stock symbol
KURA
Transactions as of
Jan 28, 2025
Transactions value $
-$38,958
Form type
4
Date filed
1/28/2025, 08:54 PM
Previous filing
Jan 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale -$17.6K -2.24K -2.41% $7.87 90.9K Jan 28, 2025 Direct F1
transaction KURA Common Stock Sale -$6.98K -887 -0.98% $7.87 90K Jan 28, 2025 Direct F2
transaction KURA Common Stock Sale -$5.5K -699 -0.78% $7.87 89.3K Jan 28, 2025 Direct F3
transaction KURA Common Stock Sale -$8.83K -1.12K -1.26% $7.87 88.2K Jan 28, 2025 Direct F4
holding KURA Common Stock 500 Jan 28, 2025 spouse's 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.
F2 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22.
F3 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
F4 Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.